Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
- Conditions
- Interventions
- First Posted Date
- 2022-06-16
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT05422508
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Korea, Republic of
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT04565015
- Locations
- 🇺🇸
Oklahoma Institute of Allergy & Asthma Clinical Research, LLC, Oklahoma City, Oklahoma, United States
🇺🇸Allergy Partners of North Texas Research, Dallas, Texas, United States
🇺🇸Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax, Virginia, United States
COVIDIG (COVID-19 Hyper-ImmunoGlobulin)
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 63
- Registration Number
- NCT04555148
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 213
- Registration Number
- NCT04238975
- Locations
- 🇰🇷
The Catholic Univ. of Korea Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 23
- Registration Number
- NCT04175522
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
- Conditions
- Interventions
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 45
- Registration Number
- NCT04003844
- Locations
- 🇰🇷
Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of
🇰🇷Kyung Hee University Medical Center, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea, Republic of
A Study of GC3107(BCG Vaccine) in Healthy Infants
- Conditions
- Interventions
- First Posted Date
- 2019-05-13
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 750
- Registration Number
- NCT03947138
- Locations
- 🇰🇷
The Catholic Universitiy of Korea St. vincent's Hospital, Suwon, Korea, Republic of
🇰🇷Greencross, Yongin, Korea, Republic of
A Study of GC1111 in Hunter Syndrom Patients
- Conditions
- Interventions
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT03920540
- Locations
- 🇰🇷
Samsug Medical Center, Seoul, Korea, Republic of
A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 41
- Registration Number
- NCT03855696
- Locations
- 🇰🇷
Yonsei Cancer Center, Yonsei University Severance Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Korea, Republic of
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT03801798
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of